Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
How I Approach Ethical Considerations for Pediatric Phase I CAR T‐Cell Trials
How I Approach Ethical Considerations for Pediatric Phase I CAR T‐Cell Trials
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Sarah W. Peters
,
Sara K. Silbert
,
Elizabeth M. Holland
,
Annette Rid
,
Rayne H. Rouce
,
Christine Grady
,
Nirali N. Shah
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Pediatric Blood & Cancer
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1002/pbc.31802
Similar Items
Integrating Palliative Care in Phase 1 Pediatric Oncology Trials: Parent Perspectives
by: Andrea Cuviello, et al.
Published: (2026)
Diagnostic pitfalls in assessment of ferritin following CAR‐T‐cell therapy: Understanding the hook effect
by: Roa Harb, et al.
Published: (2024)
Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics
by: Angela Steineck, et al.
Published: (2024)
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors
by: Aaron B. Ross, et al.
Published: (2025)
Access to CARe: A Narrative of Real‐World Medical Decision‐Making to Access Chimeric Antigen Receptor (CAR) T‐Cell Therapy in Children, Adolescents, and Young Adults
by: Angela Steineck, et al.
Published: (2025)